Cybin Provides Corporate Update on Upcoming Clinical Milestones
Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry ...
Psychology Today19h
How Wearable Technology Can Worsen Health Anxiety
Wearable technologies can measure everything from oxygen saturation to the quality of our sleep. The downside is that ...
Business Wire21h
Cybin Announces Completion of Previously Announced Share Consolidation
Cybin Inc. (NYSE American: CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolut ...
Mena FN22h
Investornewsbreaks Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Completes 38-For-1 Share Consolidation
The company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized ...
muddyrivernews22h
JWCC trustees hear report on college’s support of students’ mental health
The John Wood Community College Board of Trustees heard a report on the collaborative efforts to further support students’ ...
Scientists uncover genetic predisposition to anxiety
Investigators from the Yale Department of Psychiatry investigated the genetic profiles of more than 1 million participants ...
Dr. Liz McIngvale and Cali Werner answer questions about handling your kids' anxiety
A discussion on when the right time is to get a phone for your child and knowing when to seek out clinical help for anxiety ...
Psychology Today18h
Rethinking the Gold Standard for Autism Treatment
New research questions the necessity of high-hour interventions for autism, offering fresh insights into effective, ...